APA (7th ed.) Citation

A, B., M, W., F, M., Q, W., S, B., M, M., . . . J, B. (2023). Recurrent disability progression endpoints in multiple sclerosis clinical trials. Multiple sclerosis (Houndmills, Basingstoke, England), 29(1), 130. https://doi.org/10.1177/13524585221125382

Chicago Style (17th ed.) Citation

A, Bühler, Wolbers M, Model F, Wang Q, Belachew S, Manfrini M, Lorscheider J, Kappos L, and Beyersmann J. "Recurrent Disability Progression Endpoints in Multiple Sclerosis Clinical Trials." Multiple Sclerosis (Houndmills, Basingstoke, England) 29, no. 1 (2023): 130. https://doi.org/10.1177/13524585221125382.

MLA (9th ed.) Citation

A, Bühler, et al. "Recurrent Disability Progression Endpoints in Multiple Sclerosis Clinical Trials." Multiple Sclerosis (Houndmills, Basingstoke, England), vol. 29, no. 1, 2023, p. 130, https://doi.org/10.1177/13524585221125382.